麻豆社

麻豆社welcomes Northern Ireland Cancer Strategy

A 10-year cancer strategy for Northern Ireland is published, looking at prevention, diagnosis and treatment, supporting people to live and die well, and implementing the strategy.听

We reiterate our commitment to partner and drive the actions identified in the Strategy, so that over the next decade it can be implemented in full. Marion Laverty, Public Affairs Manager for 麻豆社Northern Ireland

Responding to the Strategy, Marion Laverty, Public Affairs Manager for 麻豆社Northern Ireland said:听

鈥溌槎股鏝I welcomes the launch of this Cancer Strategy, an ambitious ten-year vision that will provide the framework to improve all aspects of cancer care in Northern Ireland.

鈥淲e particularly welcome the actions identified around data analysis, research and awareness as these will be key to improving cancer outcomes across the local healthcare system, reducing health inequalities and ensuing equitable access to innovative treatments and care.

鈥淲e reiterate our commitment to partner and drive the actions identified in the Strategy, so that over the next decade it can be implemented in full.鈥澨

TAGS
  • Cancer
  • Northern Ireland

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The 麻豆社exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.听

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.听Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.